BridgeBio Pharma Inc (BBIO)
36.10
-0.64
(-1.74%)
USD |
NASDAQ |
Mar 26, 16:00
35.31
-0.79
(-2.19%)
After-Hours: 06:07
BridgeBio Pharma Shareholders Equity (Quarterly): -1.468B for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc | 88.20B |
| Alnylam Pharmaceuticals Inc | 67.09M |
| Catalyst Pharmaceuticals Inc | 727.63M |
| Plus Therapeutics Inc | -5.174M |
| Insmed Inc | 285.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 919.34M |
| Total Liabilities (Quarterly) | 2.377B |
| Debt to Equity Ratio | -1.173 |
| Current Ratio | 4.668 |
| Net Debt Paydown Yield | -0.00% |